Estimated changes in price discounts for tenofovir-inclusive HIV treatments following introduction of tenofovir alafenamide
- PMID: 36205353
- PMCID: PMC9698192
- DOI: 10.1097/QAD.0000000000003401
Estimated changes in price discounts for tenofovir-inclusive HIV treatments following introduction of tenofovir alafenamide
Abstract
We estimated list and net prices for tenofovir disoproxil fumarate (TDF) products Truvada, Complera, and Stribild, and their tenofovir alafenamide (TAF) versions Descovy, Odefsey, and Genvoya. Gilead offered discounts for Descovy that resulted into lower net prices compared to Truvada. This strategy encouraged patients switching from Truvada to Descovy before the availability of generic Truvada. Conversely, Gilead offered lower discounts for Odefsey and Genvoya, which resulted into higher net prices compared to Complera and Stribild.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Dickson S, Killelea A. Intentionally delayed pharmaceutical innovation under perverse incentives: Gilead's HIV pipeline as a case study. Health Aff Forefr. https://www.healthaffairs.org/do/10.1377/forefront.20210614.619677. - DOI
-
- Walensky RP, Horn T, McCann NC, Freedberg KA, Paltiel AD. Comparative pricing of branded tenofovir alafenamide-emtricitabine relative to generic tenofovir disoproxil fumarate-emtricitabine for HIV preexposure prophylaxis: a cost-effectiveness analysis. Ann Intern Med 2020; 172:583–590. - PMC - PubMed
-
- SSR Health. Available at: https://www.ssrhealth.com. [Accessed 14 June 2022]
-
- Dickson S, Gabriel N, Gellad WF, Hernandez I. Reduction in Medicaid rebates paid by pharmaceutical manufacturers for outpatient injected, inhaled, infused, implanted, or instilled drugs: the 5i loophole. J Health Polit Policy Law 2022; 10041219.doi:10.1215/03616878-10041219. [Online ahead of print]. - PubMed
-
- Hoover K, Weiming Z, Wiener J, Huang YL. Trends in truvada and descovy prescriptions for PrEP in the United States, 2014–2020. 2021. Available at: https://natap.org/2021/CROI/croi_201.htm. [Accessed 5 July 2022]
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
